Omicue Life Sciences

@UCBvbOt4FvlGy3UPqMuzuDqQ - 7 subscribers

Omicue Life Sciences is building the future of precision oncology with its Genomic-phenotypic Next-Gen Screening (GNGS) platform. We test oncology drugs directly on patient-derived tumor cells to generate real-world insights into drug response, resistance, and mechanisms of action. Unlike traditional models, GNGS captures the complexity of human cancer biology and accelerates drug discovery, clinical decision-making, and personalized medicine. On this channel, we share videos on cancer research, AI-driven drug discovery, genomics & transcriptomics, and the role of high-content imaging in oncology. Our content is tailored for oncologists, researchers, pharma leaders, investors, and patient advocates who want to understand how next-generation cancer diagnostics can improve outcomes and reduce trial-and-error in treatment. Subscribe to stay updated on breakthroughs at the intersection of oncology, genomics, and drug development.